{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:52:54Z","timestamp":1790175174009,"version":"4.1.0"},"reference-count":31,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.3201\/eid2011.140685","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T15:44:57Z","timestamp":1413387897000},"source":"Crossref","is-referenced-by-count":141,"title":["Drug-Resistant<i>Candida glabrata<\/i>Infection in Cancer Patients"],"prefix":"10.3201","volume":"20","author":[{"given":"Dimitrios","family":"Farmakiotis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Tarrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2011.140685-201410151143-R1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2011.140685-201410151143-R2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/01.md.0000091182.93122.8e","article-title":"Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.","volume":"82","author":"Antoniadou","year":"2003","journal-title":"Medicine"},{"key":"key-10.3201\/eid2011.140685-201410151143-R3","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/cncr.23466","article-title":"The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.","volume":"112","author":"Hachem","year":"2008","journal-title":"Cancer"},{"key":"key-10.3201\/eid2011.140685-201410151143-R4","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1002\/cncr.24507","article-title":"Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001\u20132007): stable incidence but changing epidemiology of a still frequently lethal infection.","volume":"115","author":"Sipsas","year":"2009","journal-title":"Cancer"},{"key":"key-10.3201\/eid2011.140685-201410151143-R5","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/jac\/dkq053","article-title":"Candidemia in adult cancer patients: risks for fluconazole-resistant isolates and death.","volume":"65","author":"Slavin","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2011.140685-201410151143-R6","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated MIC.","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2011.140685-201410151143-R7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10096-013-2009-3","article-title":"Candida glabrata: a review of its features and resistance.","volume":"33","author":"Rodrigues","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.3201\/eid2011.140685-201410151143-R8","doi-asserted-by":"publisher","first-page":"e1002718","DOI":"10.1371\/journal.ppat.1002718","article-title":"Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata.","volume":"8","author":"Singh-Babak","year":"2012","journal-title":"PLoS Pathog"},{"key":"key-10.3201\/eid2011.140685-201410151143-R9","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/cid\/cit140","article-title":"Candida glabrata and FKS mutations: witnessing the emergence of the true multi-drug resistant Candida.","volume":"56","author":"Ostrosky-Zeichner","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2011.140685-201410151143-R10","unstructured":"Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts, 4th ed. M27\u2013S4. Wayne (PA): The Institute; 2012."},{"key":"key-10.3201\/eid2011.140685-201410151143-R11","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment.","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am J Med"},{"key":"key-10.3201\/eid2011.140685-201410151143-R12","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1128\/JCM.03044-13","article-title":"The impact of new antifungal breakpoints on antifungal resistance in Candida species.","volume":"52","author":"Fothergill","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2011.140685-201410151143-R13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijantimicag.2013.09.005","article-title":"Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.","volume":"43","author":"Wisplinghoff","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid2011.140685-201410151143-R14","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1128\/AAC.00136-13","article-title":"Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.","volume":"57","author":"Shields","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2011.140685-201410151143-R15","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1128\/AAC.01451-13","article-title":"Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and echinocandin resistance.","volume":"57","author":"Shields","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2011.140685-201410151143-R16","unstructured":"Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts, 3rd ed. M27\u2013A3. Wayne (PA): The Institute; 2008."},{"key":"key-10.3201\/eid2011.140685-201410151143-R17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/cid\/ciu407","article-title":"FKS mutant Candida glabrata; risk factors and outcomes in patients with candidemia.","volume":"59","author":"Beyda","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2011.140685-201410151143-R18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/0884533610368704","article-title":"Candidemia incidence in recipients of parenteral nutrition.","volume":"25","author":"Stratman","year":"2010","journal-title":"Nutr Clin Pract"},{"key":"key-10.3201\/eid2011.140685-201410151143-R19","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/myc.12090","article-title":"Peripheral and total parenteral nutrition as the strongest risk factors for nosocomial candidemia in elderly patients: a matched case\u2013control study.","volume":"56","author":"Luzzati","year":"2013","journal-title":"Mycoses"},{"key":"key-10.3201\/eid2011.140685-201410151143-R20","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1128\/JCM.06112-11","article-title":"Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2011.140685-201410151143-R21","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1128\/AAC.03255-14","article-title":"The role of FKS mutations in C. glabrata: MIC values, echinocandin resistance, and multidrug resistance.","volume":"58","author":"Pham","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2011.140685-201410151143-R22","unstructured":"Farmakiotis D, Tarrand JJ, Kontoyiannis DP. Application of the combined CLSI\/EUCAST breakpoints for azole and echinocandin susceptibilities ofCandidaisolates in a tertiary cancer center: the emerging threat of multidrug resistance. In: Book of Abstracts of the 12th ASM Conference onCandidaand Candidiasis; New Orleans, LA; 2014 Mar 26\u201330. Oral presentation S8:5, p. 60 [cited 2014 Jun 19]. http:\/\/conferences.asm.org\/images\/2014_candida_web_program.pdf"},{"key":"key-10.3201\/eid2011.140685-201410151143-R23","unstructured":"Miyazaki T. A single amino acid mutation in IPI1 confers multi-antifungal resistance without affecting virulence inCandida glabrata. In: Book of Abstracts of the 12th ASM Conference onCandidaand Candidiasis; New Orleans, LA; 2014 Mar 26\u201330. Invited oral presentation S10C, p. 73 [cited 2014 Jun 19]. http:\/\/cofnerences.asm. org\/images\/2014_candida_web_program.pdf"},{"key":"key-10.3201\/eid2011.140685-201410151143-R24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijmm.2012.04.002","article-title":"Doxorubicin selects for fluconazole-resistant petite mutants in Candida glabrata isolates.","volume":"302","author":"Schulz","year":"2012","journal-title":"Int J Med Microbiol"},{"key":"key-10.3201\/eid2011.140685-201410151143-R25","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1128\/AAC.05947-11","article-title":"Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.","volume":"56","author":"Ben-Ami","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2011.140685-201410151143-R26","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/infdis\/jir351","article-title":"Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.","volume":"204","author":"Ben-Ami","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2011.140685-201410151143-R27","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1128\/AAC.02666-13","article-title":"In-vitro antifungal susceptibility of Candida glabrata to caspofungin and the presence of FKS mutations correlate with treatment response in an immunocompromised murine model of invasive infection.","volume":"58","author":"Fern\u00e1ndez-Silva","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2011.140685-201410151143-R28","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1128\/AAC.01271-10","article-title":"Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice.","volume":"55","author":"Ferrari","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2011.140685-201410151143-R29","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1128\/AAC.02163-13","article-title":"Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.","volume":"58","author":"Eschenauer","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2011.140685-201410151143-R30","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.1128\/AAC.01519-13","article-title":"Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?","volume":"57","author":"Espinel-Ingroff","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2011.140685-201410151143-R31","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1128\/AAC.00027-12","article-title":"The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata.","volume":"56","author":"Shields","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/20\/11\/14-0685_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:23:44Z","timestamp":1733286224000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/20\/11\/14-0685_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2011.140685","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}